Quality control of the leucorredución of platelets obtained by apheresis through Nageotte chamber and CELL-DIN Ruby

Control de calidad de la leucorredución de plaquetas obtenidas por aféresis por medio de cámara de nageotte y cell-din ruby.

Published 2014-12-16


https://doi.org/10.30554/archmed.14.2.263.2014
Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 14 No. 2
Section
Research Articles
How to Cite
Cruz Bermudez, H., Moreno Collazo, J. E., Castrillón Villada, L., Patiño, A., Forero Rincón, S., & Angarita-Fonseca, A. (2014). Quality control of the leucorredución of platelets obtained by apheresis through Nageotte chamber and CELL-DIN Ruby. Archivos De Medicina (Manizales), 14(2), 268-275. https://doi.org/10.30554/archmed.14.2.263.2014
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
DOI

https://doi.org/10.30554/archmed.14.2.263.2014
Dimensions
PlumX

How to Cite

Cruz Bermudez, H., Moreno Collazo, J. E., Castrillón Villada, L., Patiño, A., Forero Rincón, S., & Angarita-Fonseca, A. (2014). Quality control of the leucorredución of platelets obtained by apheresis through Nageotte chamber and CELL-DIN Ruby. Archivos De Medicina (Manizales), 14(2), 268-275. https://doi.org/10.30554/archmed.14.2.263.2014

Download Citation

Harold Cruz Bermudez
Jorge Enrique Moreno Collazo
Liliana Castrillón Villada
Angélica Patiño
Sandra Forero Rincón
Adriana Angarita-Fonseca
Show authors biography

Most read articles by the same author(s)

compare using two different methodologies residual white blood cell count in order to provide safer blood components. The blood components obtained from eresis offer greater safety to patients at the time of blood transfusion; verifying leukoreduction differentiator Material and Methods: A descriptive study was performed cross-sectional in Colombia Hematológica Foundation. Bogotá. Simple random sampling was performed from the list entered in a blood drive for the purpose of verification
of residual white blood cell count by Nageotte chamber and Cell Dyn Ruby © © units. For the analysis of the data measures of central tendency and dispersion for quantitative variables were applied (95%) and Spearman correlation analysis for
satisfactory procedures (t-test); Data analysis was performed on SPSS Version IBM © program 19. Results: The study population consisted of 124 samples of platelets obtained by apheresis. In relation to cell count for the two methodologies presented
an average of 0,057 vs 0,003 cells counted; the maximum value for the two methods was 0.34 to 0.44. Conclusions: The samples analyzed presented residual white blood cell counts below 5.0 x 106 estimated to set the drive as leukoreduced with this finding
value puts safety of transfused platelets obtained by apheresis aspects reactions to evidence transfusion rWBC additionally could be used safely leaving platelets into consideration the use of filters to leucorredución.

Article visits | PDF visits

Downloads

Download data is not yet available.
  1. Otter J, Cooper ES. What do the accreditation organizations expect? American Association of Blood Banks. Arch Pathol Lab Med 1999; 123(6):468-71. 2. Rivas J, Lopez E, Gastelúm C. Controversias en la transfusión de plaquetas. Rev hematol Mex 2011; 12(1):46-48. 3. Menitove JE. Process control. Standard for blood banks and transfusion services. 22nd ed. Bethesda: American Association of Blood Banks; 2003. 4. Thomas P. Analytical Approaches to the Quality Assurance of Leukocyte-Reduded Blood Components. Clinical Inmunology 1997; 17(4):45-49. 5. Inaipil SV, Romero LD, Santiago SC, Ramos GA, Rangel RS, Paquini MM, et al. Estudio comparativo de plaquetoferesis para evaluar la eficiencia en la cámara PLT-30 vs A-35 del separador celular CS 3000 plus. Ciudad de México: Memorias de la Reunión Anual de Investigación del Hospital Infantil de México Federico Gómez; 2002. 6. Aguado MJ, Villegas R, Márquez S, Corbacho B, Navarro JA. Leucorreducción universal de productos sanguíneos. Revisión sistemática de la literatura y evaluación económica. Sevilla: Agencia de Evaluación de Tecnologías Sanitarias de Andalucía; 2007. 7. Medicare, Medicaid, and CLIA Programs. Continuing Approval of AABB (Formerly the American Association of Blood Banks as a CLIA Accreditation Organization. Department of Health & Human Services (HHS) Documents / FIND. Atlanta: Centers for Medicare and Medicaid Services (CMS); 2008. 8. FDA. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance on Medical Devices: The Pre-Submission Program and Meetings With FDA Staff. Atlanta: Department of Health and Human Services Food and Drug Administration; 2013. 9. ICSH. Guidelines for the evaluation of blood cell analysers including those used for differential leucocyte and reticulocyte counting and cell marker applications. International Council for Standardization in Haematology: prepared by the ICSH Expert Panel on Cytometry. Clin Lab Haematol. 1994; 16: 157-74. 10. Crucian BE, Sams CF. The use of a spaceflightcompatible device to perform WBC surface marker staining and whole-blood mitogenic activation for cytokine detection by flow cytometry. J Gravit Physiol. 1999; 6(1):33-34. 11. Galel SA, Gaitan J, Yu DT, Tolentino L, Webster J, Sugasawara E, et al. Frequency and specificity of the Trima Accel “verify WBCs” advisory: considerations for product management. Transfusion 2012; 52(5):995-1002. 12. Ali SF. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods. Transfus Apher Sci 2011; 44(1):11-3. 13. Fischer JC, Quenzel EM, Moog R, Wenzel F, Rieth- Fischer JC, Quenzel EM, Moog R, Wenzel F, Riethmacher R, Tutschek B, Giers G. Reducing costs in flow-cytometric counting of residual white blood cells in blood products: utilization of a singleplatform bead-free flow-rate calibration method. Transfusion 2011; 51(7):1431-8. 14. Young J. Component Preparation. In: Rudmann S. Textbook of blood banking and transfusion medicine. Philadelphia: WB Saunders Company; 1994. 15. Stegmayr B, Ptak J, Wikström B et al. World apheresis registry 2003-2007 data. Transfus Apher Sci 2008; 39(3):247-254. 16. Mathes GA. Options and cost effectiveness of multicomponents blood collection. Transfusion Aphr Science 2002: 115-121. 17. Osta V, Segura C, Tissera G, Ayuso C. Estudio de eficiencia y sensibilidad de alarmas de dos analizadores hematológicos en un hospital pediátrico. Acta Bioquím Clín Latinoam 2014; 48(1):71-9. 18.Saarinen UM, Kekomäki R, Siimes MA, Myllylä G. Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte free blood components. Blood 1990; 75:512-517.

Information

Google Scholar Profile

Author Guidelines